Geopolitical worries have added another layer of volatility to an already-jumpy market as investors price in the possibility of escalating conflict between Russia and Ukraine

Hong Kong's No-2 official John Lee said on Saturday that China would help the city cope with its expanding outbreak, but there were no plans for a mainland-style lockdown for now

Critics call for an end to favourable tax regimes for oil giants, which are again recording multi-billion-dollar profits while 'pushing our world closer to catastrophic climate change'

Under the Biden administration, road safety officials are taking a closer look at Tesla and its much-touted 'autonomous' and 'full self driving' claims, which critics say are irresponsible and misleading

The 29-year-old Bankman-Fried, now worth about $25 billion, is an advocate of better access to crypto and greater official oversight. He also believes in giving away a large chunk of his wealth

China's Dongfang Jingyuan Electron, which makes software for chip manufacturing procedures, has denied reports about alleged IP theft from Dutch lithography giant ASML Holding

Network gear maker Cisco Systems has made a takeover offer worth more than $20 billion for software maker Splunk Inc, the Wall Street Journal has reported

Secretary of State Antony Blinken is set to announce the opening of a new embassy in the Solomon Islands during a visit to nearby Fiji – 29 years after the US downgraded its diplomatic presence

Former employees are seeking compensation from the home appliance maker over poor working and living conditions at ATA factories. The case follows a wave of labour disputes in Malaysia

Business is booming but the company's biggest factory in San Francisco has seen a spate of sexual harassment lawsuits, years of racism allegations and even a murder in its parking lot

White House warnings of a possibly imminent Russian invasion of Ukraine reverberated through financial markets with stocks tumbling on Wall Street on Friday and oil prices surging.

China's medical products regulator has given conditional approval for Pfizer's Covid-19 treatment Paxlovid, making it the first pill approved in the country to treat the disease.